Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-25-003710
Filing Date
2025-10-01
Accepted
2025-10-01 16:54:55
Documents
1
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3981
  Complete submission text file 0000929638-25-003710.txt   5444
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4868 RUE LEVY SUITE 220 SAINT-LAURENT Quebec, Canada H4R2P1
Business Address
Sweiti Hussein (Reporting) CIK: 0002088436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41854 | Film No.: 251365297